Similar to Semaglutide, Tirepatide is FDA approved for both diabetes and weight loss.
What is the difference between Tirzepatide and Semaglutide?
What makes these two medications different is Semaglutide is a single agonist that works on one receptor site, GLP-1, while Tirzepatide is a dual agonist the works on both GLP-1 and GIP receptors. Tirzepatide brand named version include Mounjaro and Zepbound.
Studies have shown patients who use Tirzepatide have lost over 20% of their body weight due to it reducing appetite, slowing down the speed the stomach’s processessing food, which makes its users feel full faster and longer, and its ability to reduce blood sugar levels. Tirzepatide is strong weapon at helping to reduce calories and cravings.